Oruka Therapeutics Inc. Common Stock vs Unusual Machines Inc. Common Stock — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B), while Unusual Machines Inc. Common Stock trades at $17.15 (market cap $885.73M). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 5.7× Unusual Machines Inc. Common Stock's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Unusual Machines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Unusual Machines Inc. Common Stock for 0 Days on average.
| ORKA | UMAC | |
|---|---|---|
Market Cap | $5.08B | $885.73M |
Volume | 685,276 | 3,688,533 |
Sector | Health | Technology |
52-Week High | $113.08 | $34.06 |
52-Week Low | $26.19 | $7.76 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.21B | $572.51M |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →Unusual Machines Inc. manufactures and sells drone components and complete drones for consumer, enterprise, and defense markets, operating brands including Fat Shark FPV goggles and the Rotor Riot retail platform, with US-based, NDAA-compliant manufacturing.
Read more on UMAC →